The FDA approved AstraZeneca’s Koselugo for children 1+ with NF1 and inoperable nerve tumors, expanding treatment options with an established safe dose.
FDA Expands Approval For AstraZeneca’s Drug For Pediatric Patients With Rare Type Of Cancer
Where Today's News Shapes Tomorrow
